Northwestern Mutual Wealth Management
BLRX

Northwestern Mutual Wealth Management’s BioLineRX BLRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed -$1K – 2356
2016
Q3 		$1K Buy
+1
New +$533 ﹤0.01% 2013

Other funds holding BLRX

SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's BLRX Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of BioLineRX (BLRX) in Q4 2016, closing a stake of 1 share — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in BLRX in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 22 funds tracked by Wall St. Rank hold BLRX as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining BioLineRX position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 BioLineRX share in Q4 2016, an estimated $1K.
  • Northwestern Mutual Wealth Management first reported a position in BioLineRX in Q3 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's BioLineRX position peaked at $1K in Q3 2016.
  • 22 funds tracked by Wall St. Rank held BioLineRX as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.